In the pulmonary microvasculature of COVID-19 patients, Magro et al. found deposits of the terminal complement complex C5b-9, the membrane attack complex (MAC), C4d, mannose-binding lecithin (MBL), and MBL-associated serine protease 2 (MASP2). The gene discussed is MASP2; the disease is COVID-19.